AVENUE SOLUTIONS

Lobbying for INCYTE CORPORATION · Biopharmaceutical company

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

Delaware

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

Issues related to 340b; Expiring healthcare extenders; Issues related to Priority Review Voucher (PRV) program

Medicare/Medicaid

Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.